NorthStrive Biosciences Files New U.S. Patent Application for EL-22 Targeting Muscle Preservation in Humans
PUBLISHED Tuesday, April 28, 2026 · pmgc holdings inc.
AI BRIEFING
- ⬤ NorthStrive Biosciences files patent application for EL-22 targeting muscle preservation
- ⬤ EL-22 aims to prevent muscle loss and atrophy in humans
- ⬤ Company seeks to develop new treatment for muscle-related disorders and injuries
ADVERTISEMENT